Thomas E. Van Dyke,Michael Holick,Alpdogan Kantarci,Hatice Hasturk
申请号:
US13705471
公开号:
US20130108688A1
申请日:
2012.12.05
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention provides improved systems and methods for the local delivery of H2 antagonists. The inventive methods include topical administration of an effective amount of a H2 antagonist encapsulated in liposomes. In certain embodiments, the H2 antagonist, for example, Cimetidine, is encapsulated into paucilamellar liposomes, such as NOVASOME® microvesicles. Also provided are pharmaceutical compositions comprising liposome-encapsulated H2 antagonists. The methods and compositions of the present invention may be used to treat any disease state or condition where local administration of H2 antagonists is beneficial.